These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 4092284)

  • 1. Non-enzymatic oxidation of the new cardiotonic agent denopamine and its derivatives: comparison with enzymatic oxidation.
    Suzuki T; Hashimura Y; Takeyama S
    Chem Pharm Bull (Tokyo); 1985 Sep; 33(9):3859-67. PubMed ID: 4092284
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro metabolism of the new cardiotonic agent denopamine (TA-064) by rat and rabbit liver preparations. Oxidation, methylation, and glucuronidation.
    Suzuki T; Hashimura Y; Takeyama S
    Drug Metab Dispos; 1985; 13(2):246-54. PubMed ID: 2859176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of denopamine in human and dog plasma by high-performance liquid chromatography with electrochemical detection.
    Tagawa K; Ueki T; Mizobe M; Noda K; Samejima M
    J Chromatogr; 1990 Aug; 529(2):500-6. PubMed ID: 2229268
    [No Abstract]   [Full Text] [Related]  

  • 4. Improved separation of the denopamine metabolites using capillary column gas chromatography-mass spectrometry.
    Suzuki T; Hashimura Y; Takeyama S
    Chem Pharm Bull (Tokyo); 1985 Jun; 33(6):2549-52. PubMed ID: 4064212
    [No Abstract]   [Full Text] [Related]  

  • 5. Metabolism of denopamine, a new cardiotonic agent, in the rat and dog.
    Furuuchi S; Naito K; Otsuka M; Harigaya S
    Drug Metab Dispos; 1985; 13(5):620-6. PubMed ID: 2865114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic fate of the new cardiotonic denopamine in animals. 4th communication: effects of coadministered drugs on the plasma concentration and metabolism of denopamine in dogs.
    Furuuchi S; Naito K; Yamada Y; Otsuka M; Harigaya S
    Arzneimittelforschung; 1986 Apr; 36(4):665-7. PubMed ID: 3718591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physico-chemical properties and stabilities of a new positive inotropic agent, 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl] -2(1H)-quinolinone (OPC-8212).
    Shimizu T; Osumi T; Niimi K; Nakagawa K
    Arzneimittelforschung; 1984; 34(3A):334-41. PubMed ID: 6540087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular characterization of the pharmacological selectivity and tachyphylactic properties of denopamine for the human beta adrenergic receptors.
    Suzuki T; Nantel F; Bonin H; Valiquette M; Bouvier M
    J Pharmacol Exp Ther; 1993 Nov; 267(2):785-90. PubMed ID: 7902433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of denopamine on the phosphorylation of cardiac muscle proteins in the perfused guinea-pig heart. Comparison with isoproterenol.
    Sasaki Y; Yabana H; Nagao T; Takeyama S
    Biochem Pharmacol; 1988 Feb; 37(4):679-86. PubMed ID: 2829921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical effects of denopamine in patients with cardiac operations].
    Sekino Y; Kikuchi S; Tabayashi K; Itoh T; Suzuki Y; Mohri H
    Rinsho Kyobu Geka; 1989 Dec; 9(6):589-93. PubMed ID: 9308666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on cardiac ingredients of plants. V. Chemical transformation of proscillaridin and biological activities of derivatives.
    Mori J; Nagai S; Sakakibara J; Takeya K; Hotta Y
    Chem Pharm Bull (Tokyo); 1988 Jan; 36(1):48-59. PubMed ID: 3378308
    [No Abstract]   [Full Text] [Related]  

  • 12. Behaviour of 3-methyl-2-benzothiazolone azines of carbonyl compounds in high-performance liquid chromatography.
    Chiavari G; Facchini MC; Fuzzi S
    J Chromatogr; 1987 Jan; 387():459-66. PubMed ID: 3558637
    [No Abstract]   [Full Text] [Related]  

  • 13. High-performance liquid chromatography and gas chromatography-mass spectrometry determination of specific lipid peroxidation products in vivo.
    Hughes H; Smith CV; Horning EC; Mitchell JR
    Anal Biochem; 1983 Apr; 130(2):431-6. PubMed ID: 6869831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular effects of the new positive inotropic agent denopamine with special reference to species difference and the effect on failing heart.
    Ikeo T; Nagao T; Murata S; Yabana H; Sato M; Nakajima H
    Arzneimittelforschung; 1986 Jul; 36(7):1063-8. PubMed ID: 3768073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous analysis of a new cardiotonic agent, MDL 17,043, and its major sulfoxide metabolite in plasma by high-performance liquid chromatography.
    Chan KY; Ohlweiler DF; Lang JF; Okerholm RA
    J Chromatogr; 1984 Mar; 306():249-56. PubMed ID: 6232282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Silylation of dithranol and derivatives of its oxidation].
    Prognon P; Gond A; Dubertret L; Mahuzier G
    Ann Pharm Fr; 1982; 40(4):329-37. PubMed ID: 7158956
    [No Abstract]   [Full Text] [Related]  

  • 17. [Acute and chronic effects of oral cardiotonic agent, denopamine (TA-064) in patients with heart failure].
    Inden M; Yamamuro M; Murayama S; Noda E; Tanimura H; Takasaki H; Konishi T; Nakano T; Takezawa H
    Kokyu To Junkan; 1986 May; 34(5):541-6. PubMed ID: 3738247
    [No Abstract]   [Full Text] [Related]  

  • 18. Isolation and characterization of urinary metabolites of arbaprostil in the rat.
    Thornburgh BA; Shaw SR; Wickrema Sinha AJ
    Eur J Drug Metab Pharmacokinet; 1986; 11(1):61-9. PubMed ID: 3720796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of saterinone in plasma by high-performance liquid chromatography.
    Rudolph M
    J Chromatogr; 1989 Dec; 497():342-8. PubMed ID: 2625472
    [No Abstract]   [Full Text] [Related]  

  • 20. High-performance liquid chromatographic determination of milrinone in biological tissues and fluids.
    Verrijk R; van Rooij HH; Wemer J; Porsius AJ
    J Chromatogr; 1989 Jun; 491(1):265-8. PubMed ID: 2793979
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.